Robert Hadfield

Robert Hadfield is a declared insider of Alaunos Therapeutics, Inc., with filings sourced from SEC (Form 4). Between 6 January 2019 and 4 March 2021, the trades on record add up to 5 filings.

On the market, this insider has only sold: 2 sales, €136k in total. The rest of the record consists of 3 share grants. 2021 to date brings no purchases and 1 sale.

Most recently, on 8 March 2021, the filings show a share grant in Alaunos Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.